Relating to participation in federal prescription drug pricing programs.
HB 5553 allows West Virginia's Public Employees Insurance Agency (PEIA) and the Department of Human Services to voluntarily join federal prescription drug pricing programs, such as those using international reference pricing models. The bill permits these agencies to negotiate drug prices directly with manufacturers or use federal benchmarks for reimbursement, but only if it saves money for the state and maintains beneficiary access to necessary medications. It explicitly prohibits requiring the state to adopt federal drug lists or override existing state pharmacy benefit rules. Both agencies must report annually to the legislature on program participation, estimated savings, and any access issues.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 16, 2026
Last action Feb 16, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
2
Feb 16, 2026
Committee
To House Health and Human Resources
lower
Feb 16, 2026
Introduced
Introduced in House
lower
Feb 16, 2026
Committee
To Health and Human Resources
lower
1 primary · 4 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 5553
Scope: WV
Hi! I can help you understand HB 5553. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline